Radioactive drug development is a multi-disciplinary task, therefore, in a concerted effort, dedicated scientists and experts from different fields of specialisation have contributed to this book. It is presented in two sections. Section 1 contains basic principles and methods used for analysis, information on the chemistry of technetium and on radiopharmaceuticals labelled with technetium-99m, the characteristics of the 99 Mo/99mTc-generator, of 'kits' and formulations for in-vitro labelling, and special safety aspects for in-vivo labelling of blood cells. Section 2 contains monographs of 99mTc-radiopharmaceuticals used in nuclear medicine. Each monograph includes information on the chemistry, formulation, commercial products and trade names, factors affecting in-vivo performance, clinical information on pharmacokinetics, as well as details concerning the clinical application and the radiation dose to patients.
Produkteigenschaften
- Artikelnummer: 9783540339892
- Medium: Buch
- ISBN: 978-3-540-33989-2
- Verlag: Springer Berlin Heidelberg
- Erscheinungstermin: 07.11.2006
- Sprache(n): Englisch
- Auflage: 2007
- Produktform: Gebunden, HC runder Rücken kaschiert
- Gewicht: 717 g
- Seiten: 345
- Format (B x H x T): 160 x 241 x 25 mm
- Ausgabetyp: Kein, Unbekannt